| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $79.4M | -0.4% | -0.5% |
| Cost of Revenue | $20.5M | +2.1% | +2.7% |
| Gross Profit | $58.9M | -1.2% | -1.5% |
| R&D Expense | $19.1M | +0.6% | -10.4% |
| SG&A Expense | $12.6M | +0.0% | +1.8% |
| Operating Income | -$6.9M | +4.4% | +37.5% |
| Pre-tax Income | -$10.2M | +55.2% | +45.1% |
| Income Tax | $209K | -10.7% | +2.0% |
| Net Income | -$10.4M | +54.7% | +44.6% |
| EPS (Basic) | -$0.25 | +55.4% | +47.9% |
| EPS (Diluted) | -$0.25 | +55.4% | +47.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $52.3M | +10.4% | -8.6% |
| Current Assets | $122.7M | +4.5% | +1.9% |
| Total Assets | $201.6M | +3.0% | +6.0% |
| Current Liabilities | $249.9M | +1.4% | +10.5% |
| Long-term Debt | $124.2M | +1.8% | +7.5% |
| Total Liabilities | $393.5M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.7M | — | — |
| Capital Expenditures | $7.6M | — | — |
| Investing Cash Flow | -$7.6M | — | — |
| Financing Cash Flow | -$1.5M | — | — |
| Free Cash Flow | $3.1M | — | — |
| +8.9% |
| Stockholders' Equity | -$191.9M | -0.2% | -12.1% |